🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/04/2014 12,14 12,26 10,56 11,00 -9,84% 14,00% 2.241.000
25/04/2014 12,48 12,52 11,87 12,20 -3,40% 5,21% 907.400
24/04/2014 12,99 13,18 12,00 12,63 -1,41% 9,08% 909.000
23/04/2014 13,55 13,73 12,60 12,81 -5,25% 8,41% 1.075.700
22/04/2014 13,02 14,39 13,02 13,52 +2,89% 10,52% 2.090.400
21/04/2014 12,53 13,31 12,43 13,14 +2,90% 7,02% 1.307.200
17/04/2014 12,32 13,07 11,67 12,77 +3,07% 11,36% 2.834.100
16/04/2014 11,45 12,97 11,42 12,39 +8,49% 13,54% 2.969.000
15/04/2014 12,40 12,67 10,32 11,42 -8,57% 18,98% 5.978.500
14/04/2014 13,76 13,76 12,32 12,49 -4,87% 10,47% 3.261.700
11/04/2014 15,72 15,97 12,84 13,13 -17,27% 19,90% 3.983.900
10/04/2014 16,86 16,94 15,14 15,87 -6,15% 10,68% 1.362.500
09/04/2014 16,35 17,09 16,30 16,91 +3,17% 4,83% 1.644.100
08/04/2014 16,86 17,25 15,62 16,39 -2,03% 9,66% 1.645.800
07/04/2014 16,00 17,37 15,56 16,73 +3,21% 11,31% 1.976.000
04/04/2014 17,16 17,50 15,60 16,21 -5,59% 11,07% 2.365.700
03/04/2014 17,95 18,64 16,59 17,17 -4,45% 11,42% 1.775.000
02/04/2014 18,14 18,32 17,51 17,97 -1,70% 4,47% 1.515.100
01/04/2014 16,37 18,87 16,36 18,28 +11,33% 15,33% 3.541.000
31/03/2014 15,45 16,49 15,20 16,42 +5,12% 8,35% 1.940.900
28/03/2014 16,30 16,92 15,46 15,62 -4,35% 8,96% 1.484.900
27/03/2014 16,14 17,38 15,38 16,33 -0,21% 12,39% 1.845.700
26/03/2014 17,26 18,25 16,29 16,37 -4,97% 11,36% 1.919.900
25/03/2014 17,71 17,93 16,18 17,22 -0,86% 9,88% 3.495.500
24/03/2014 21,05 21,10 15,97 17,37 -16,09% 24,35% 7.561.900
21/03/2014 23,80 23,94 20,17 20,70 -13,06% 15,82% 4.096.300
20/03/2014 23,42 24,17 22,63 23,81 +1,23% 6,57% 1.107.200
19/03/2014 24,21 24,77 23,04 23,52 -2,45% 7,15% 1.235.800
18/03/2014 22,67 24,22 22,12 24,11 +6,35% 9,26% 1.776.200
17/03/2014 23,05 23,57 22,56 22,67 -1,52% 4,38% 1.189.500